100 related articles for article (PubMed ID: 23101455)
1. Interleukin-6 as a therapy target in oral squamous carcinoma.
Culig Z
Expert Opin Ther Targets; 2013 Jan; 17(1):53-9. PubMed ID: 23101455
[TBL] [Abstract][Full Text] [Related]
2. Humanized anti-interleukin-6 receptor antibody suppresses tumor angiogenesis and in vivo growth of human oral squamous cell carcinoma.
Shinriki S; Jono H; Ota K; Ueda M; Kudo M; Ota T; Oike Y; Endo M; Ibusuki M; Hiraki A; Nakayama H; Yoshitake Y; Shinohara M; Ando Y
Clin Cancer Res; 2009 Sep; 15(17):5426-34. PubMed ID: 19706815
[TBL] [Abstract][Full Text] [Related]
3. Insulin-like growth factor-I receptor signal transduction and the Janus Kinase/Signal Transducer and Activator of Transcription (JAK-STAT) pathway.
Himpe E; Kooijman R
Biofactors; 2009; 35(1):76-81. PubMed ID: 19319849
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-1 regulates interleukin-6 secretion in human oral squamous cell carcinoma in vitro: possible influence of p53 but not human papillomavirus E6/E7.
Woods KV; Adler-Storthz K; Clayman GL; Francis GM; Grimm EA
Cancer Res; 1998 Jul; 58(14):3142-9. PubMed ID: 9679982
[TBL] [Abstract][Full Text] [Related]
5. Cepharanthin-enhanced radiosensitivity through the inhibition of radiation-induced nuclear factor-kappaB activity in human oral squamous cell carcinoma cells.
Tamatani T; Azuma M; Motegi K; Takamaru N; Kawashima Y; Bando T
Int J Oncol; 2007 Oct; 31(4):761-8. PubMed ID: 17786306
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-6 promotes 2-deoxyglucose uptake through p44/42 MAPKs activation via Ca2+/PKC and EGF receptor in primary cultured chicken hepatocytes.
Suh HN; Lee YJ; Han HJ
J Cell Physiol; 2009 Mar; 218(3):643-52. PubMed ID: 19006119
[TBL] [Abstract][Full Text] [Related]
7. Herbimycin A, a tyrosine kinase inhibitor, impairs hypercalcemia associated with a human squamous cancer producing interleukin-6 in nude mice.
Moriyama K; Williams PJ; Niewolna M; Dallas MR; Uehara Y; Mundy GR; Yoneda T
J Bone Miner Res; 1996 Jul; 11(7):905-11. PubMed ID: 8797110
[TBL] [Abstract][Full Text] [Related]
8. Model-driven experimental analysis of the function of SHP-2 in IL-6-induced Jak/STAT signaling.
Dittrich A; Quaiser T; Khouri C; Görtz D; Mönnigmann M; Schaper F
Mol Biosyst; 2012 Aug; 8(8):2119-34. PubMed ID: 22711165
[TBL] [Abstract][Full Text] [Related]
9. The nonsteroidal anti-inflammatory drug sulindac causes down-regulation of signal transducer and activator of transcription 3 in human oral squamous cell carcinoma cells.
Nikitakis NG; Hamburger AW; Sauk JJ
Cancer Res; 2002 Feb; 62(4):1004-7. PubMed ID: 11861373
[TBL] [Abstract][Full Text] [Related]
10. Clinical Roles of Interleukin-6 and STAT3 in Oral Squamous Cell Carcinoma.
Shinagawa K; Yanamoto S; Naruse T; Kawakita A; Morishita K; Sakamoto Y; Rokutanda S; Umeda M
Pathol Oncol Res; 2017 Apr; 23(2):425-431. PubMed ID: 27744625
[TBL] [Abstract][Full Text] [Related]
11. Regulation of IL-6-type cytokine responses by MAPKs.
Costa-Pereira AP
Biochem Soc Trans; 2014 Feb; 42(1):59-62. PubMed ID: 24450628
[TBL] [Abstract][Full Text] [Related]
12. Hepatocyte growth factor/scatter factor-induced activation of MEK and PI3K signal pathways contributes to expression of proangiogenic cytokines interleukin-8 and vascular endothelial growth factor in head and neck squamous cell carcinoma.
Dong G; Chen Z; Li ZY; Yeh NT; Bancroft CC; Van Waes C
Cancer Res; 2001 Aug; 61(15):5911-8. PubMed ID: 11479233
[TBL] [Abstract][Full Text] [Related]
13. In vitro cytokine expression in in situ-like areas of malignant neoplasia.
Martinez EF; Napimoga MH; Montalli VA; de Araújo NS; de Araújo VC
Arch Oral Biol; 2013 May; 58(5):552-7. PubMed ID: 22749497
[TBL] [Abstract][Full Text] [Related]
14. Significance of interleukin-6 signaling in the resistance of pharyngeal cancer to irradiation and the epidermal growth factor receptor inhibitor.
Chen CC; Chen WC; Lu CH; Wang WH; Lin PY; Lee KD; Chen MF
Int J Radiat Oncol Biol Phys; 2010 Mar; 76(4):1214-24. PubMed ID: 20206020
[TBL] [Abstract][Full Text] [Related]
15. Cyclooxygenase-2-dependent activation of signal transducer and activator of transcription 3 by interleukin-6 in non-small cell lung cancer.
Dalwadi H; Krysan K; Heuze-Vourc'h N; Dohadwala M; Elashoff D; Sharma S; Cacalano N; Lichtenstein A; Dubinett S
Clin Cancer Res; 2005 Nov; 11(21):7674-82. PubMed ID: 16278387
[TBL] [Abstract][Full Text] [Related]
16. 17-hydroxy-jolkinolide B inhibits signal transducers and activators of transcription 3 signaling by covalently cross-linking Janus kinases and induces apoptosis of human cancer cells.
Wang Y; Ma X; Yan S; Shen S; Zhu H; Gu Y; Wang H; Qin G; Yu Q
Cancer Res; 2009 Sep; 69(18):7302-10. PubMed ID: 19706767
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-6 regulation of prostate cancer cell growth.
Culig Z; Steiner H; Bartsch G; Hobisch A
J Cell Biochem; 2005 Jun; 95(3):497-505. PubMed ID: 15838876
[TBL] [Abstract][Full Text] [Related]
18. The dietary phytochemical 3,3'-diindolylmethane induces G2/M arrest and apoptosis in oral squamous cell carcinoma by modulating Akt-NF-κB, MAPK, and p53 signaling.
Weng JR; Bai LY; Chiu CF; Wang YC; Tsai MH
Chem Biol Interact; 2012 Feb; 195(3):224-30. PubMed ID: 22290291
[TBL] [Abstract][Full Text] [Related]
19. JAK/STAT pathway plays a critical role in the proinflammatory gene expression and apoptosis of RAW264.7 cells induced by trichothecenes as DON and T-2 toxin.
Wang X; Liu Q; Ihsan A; Huang L; Dai M; Hao H; Cheng G; Liu Z; Wang Y; Yuan Z
Toxicol Sci; 2012 Jun; 127(2):412-24. PubMed ID: 22454431
[TBL] [Abstract][Full Text] [Related]
20. Accelerated in vivo growth of prostate tumors that up-regulate interleukin-6 is associated with reduced retinoblastoma protein expression and activation of the mitogen-activated protein kinase pathway.
Steiner H; Godoy-Tundidor S; Rogatsch H; Berger AP; Fuchs D; Comuzzi B; Bartsch G; Hobisch A; Culig Z
Am J Pathol; 2003 Feb; 162(2):655-63. PubMed ID: 12547723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
